A scanning laser ophthalmoscope (SLO) was used to examine the fundi of 54 diabetic patients through undi 
METHODS
Patients were recruited into the study from the diabetic eye clinic over a 6 month period. They were excluded if they were not mobile, or were unwilling to participate in the study. Both new and review patients were included in the study. Some patients had already had laser therapy.
All patients underwent scanning laser ophthalmoscopy whilst their pupils were undilated. This was performed by an experienced ophthalmic photographer who recorded views of the optic discs, maculae and peripheral retina to include a 60° field, using the helium-neon laser of the 
RESULTS
One hundred and eight eyes of 54 patients were examined by the two techniques. In 5 eyes the SLO images were too poor to interpret, and in a further 7 the images were poor but usable (Table I) . Cataracts prevented a view of the fun dus in 2 eyes, and in another 2 eyes (of 1 patient) made the image poor, but in the latter case the SLO image was more useful than the clinical view. In 4 eyes of 2 patients the pupils were too small to allow an adequate view with the SLO, but they had clear media and it is likely that an adequate assessment could have been made after dilata tion with tropic amide alone.
The results for the remaining 103 eyes are shown in Table II .
Background retinopathy. In 76 of 82 eyes (92.7%) the two techniques were in agreement. Sixty-five of these had no other retinopathy. The SLO failed to detect retinopathy in 5 eyes, but in 3 of these it was minimal.
Preprol(ferative retinopathy. There was agreement for 5 eyes. This includes 1 eye in which the SLO suggested new vessels but the same area was recorded as IRMA clini cally, and has been recorded as a preproliferative change (IRMA) seen by both techniques. On further review this area has remained static. Clinical examination missed pre proliferative signs in 3 eyes, 2 of which had venous bead ing, a sign which is clearly detected on the high-contrast black and white SLO images. The SLO failed to detect signs in 8 eyes, 5 of which had cotton wool spots, which do not show up well, and 3 of which had IRMA.
Proliferative retinopath.v. There was agreement between the two techniques for 7 cases of proliferative change. The SLO missed 4 cases of new vessels at the optic disc, but on checking the clinical data 3 of these were inactive vessels following laser treatment, and the fourth had a vitreous haemorrhage. The SLO missed 1 area of new vessels else where, but these too were inactive.
In 2 cases the SLO proved superior at detecting pro liferative retinopathy. In 1 eye a cataract precluded a clini cal view of new vessels at the optic disc, but these were detected with the SLO. After urgent cataract surgery the new vessels were confirmed clinically. In another eye, NVE were seen with the SLO alone. At the next review, the vessels were noted clinically.
Maculopathy. There was agreement for 27 of 34 (79.4%) eyes. The SLO missed 5 cases of exudative maculopathy, 
DISCUSSION
In order to be a useful screening tool in diabetic ret inopathy, the SLO should be simple enough to use, be cost-effective, must not miss retinopathy requiring treat ment or closer monitoring (high sensitivity), and must not cause the referral of too many unnecessary cases for further examination (low specificity). " Whilst it is not as mobile or as simple to use as the non-mydriatic fundus camera, an ophthalmic photographer can readily become competent in its use, It is expensive to purchase, but after the initial capital outlay the running costs are low: apart from the photographer's time and the reporting time, the only cost is the U-Matic videotape which can store results from 30 patients on one cassette and which can be re-used if a permanent record is not required after the images have been reported. If desired a print-out can be made from the frame-grabber which is an integral part of the equipment.
This study set out to find how reliable the SLO was at detecting retinopathy. There has been concern with non mydriatic fundus cameras that they could miss new vessels, particularly those which were growing forwards into the vitreous as they would not be in focus. 6 The SLO has a much greater depth of field and such vessels ought not to be missed. At first it seemed disappointing that any new vessels had been missed, but when the relevant cases were examined more closely it was apparent that this only applied to regressing or inactive vessels (i.e. the vessels had been previously noted, and following laser treatment were either static or regressing leaving a mainly fibrotic remnant), the only exception being a patient with a vit reous haemorrhage -a reason for clinical review anyway.
The SLO missed 4 cases of new vessels at the optic disc, but on checking the clinical data 3 of these were inactive vessels following laser treatment, and the fourth was the patient with a vitreous haemorrhage. The SLO missed 1 area of new vessels elsewhere but these too were inactive.
Therefore there were no eyes with active new vessels which would not have been referred. In 2 eyes the SLO detected new vessels which were missed by conventional examination but which were subsequently confirmed clinically. It may be that the SLO is more useful than clini cal examination alone in assessing new vessels after laser treatment to see whether they are still active; that is, if they fail to show well on the SLO this may signify regression, saving unnecessarily frequent clinic visits to monitor vessels or to undergo fluorescein angiography. This is the subject of a separate study. It is important to note that in 2 cases the SLO detected active new vessels which were missed on clinical examination but which were confirmed subsequently.
Preproliferative changes were not seen so easily, and in particular cotton wool spots were missed in several patients. However, the authors have found that with more experience these are becoming easier to identify. The IRMA that were missed were both very subtle changes. From this study it is suggested that diabetic patients could safely be examined using the SLO as a screening tool to detect changes in retinopathy and not just for a baseline screen. Patient compliance with follow-up would be improved as, with few exceptions, patients would require no mydriasis, and they could attend whenever the photographer was available rather than having to attend a specific ophthalmologist's clinic. However, the videotape would still need to be viewed by an experienced clinician.
Key words: Diabetic retinopathy, Scanning laser ophthalmoscope, Screening.
